Search results for: 'api frost radar'

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

Over the past 2 years the global pharmaceutical industry has been shifting its focus towards the emerging market such as India. The CRAMS segment in India is expected to be one of the biggest beneficiaries of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery t...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

The research service provides an overview of the convergence between medical imaging and IT in Asia Pacific medical imaging with 2009 as the base year. It provides an introduction, impact, implications and Frost & Sullivan recommendation on the convergence between medical imaging and IT.

In this first Customer Experience Management report for Malaysias Medical Insurance industry, Frost & Sullivan explores the relationship of the experiences provided by medical insurance companies for its customers. We look at the critical factors that influence customer behaviours throughout the three phases (pre-purchase, purchase and post-purcha...

Asia-Pacific represents the fastest growing region for healthcare information technology (healthcare IT) solutions across the world. Rapidly changing demographic factors coupled with fast-moving government policies and legislations are allowing advanced IT tools to penetrate the market. These tools have the potential to change existing healthcare p...

03 Jul 2015  |  Asia Pacific  |  Market Research

Analysis of The Telemedicine Market in Asia-Pacific

Affordable Telemedicine Services Are Enabling Business Model Evolution

Infographics

×

Telemedicine is not a new concept in healthcare; it has been practiced in the form of pilots and charitable projects for over a decade across Asia-Pacific countries. However, recent advancements in information and communication technologies have led to a significant decrease in the costs associated with telemedicine, spurring a sudden market boom. ...